BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 22006331)

  • 21. Differential capacity of human skin dendritic cells to polarize CD4+ T cells into IL-17, IL-21 and IL-22 producing cells.
    Penel-Sotirakis K; Simonazzi E; Péguet-Navarro J; Rozières A
    PLoS One; 2012; 7(11):e45680. PubMed ID: 23226194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human langerhans cells are more efficient than CD14(-)CD1c(+) dermal dendritic cells at priming naive CD4(+) T cells.
    Furio L; Briotet I; Journeaux A; Billard H; Péguet-Navarro J
    J Invest Dermatol; 2010 May; 130(5):1345-54. PubMed ID: 20107482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD34-derived human Langerhans cells stimulate a T helper type 2 response independently of extracellular-signal-regulated kinase phosphorylation.
    Duraisingham SS; Hornig J; Gotch F; Patterson S
    Immunology; 2010 Oct; 131(2):210-9. PubMed ID: 20465567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of dendritic cell subsets in the induction of oral tolerance and immunity.
    Fleeton M; Contractor N; Leon F; He J; Wetzel D; Dermody T; Iwasaki A; Kelsall B
    Ann N Y Acad Sci; 2004 Dec; 1029():60-5. PubMed ID: 15681744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha 6 integrins are required for Langerhans cell migration from the epidermis.
    Price AA; Cumberbatch M; Kimber I; Ager A
    J Exp Med; 1997 Nov; 186(10):1725-35. PubMed ID: 9362532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The balance between immunity and tolerance: the role of Langerhans cells.
    Mutyambizi K; Berger CL; Edelson RL
    Cell Mol Life Sci; 2009 Mar; 66(5):831-40. PubMed ID: 19002380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skin langerin+ dendritic cells transport intradermally injected anti-DEC-205 antibodies but are not essential for subsequent cytotoxic CD8+ T cell responses.
    Flacher V; Tripp CH; Haid B; Kissenpfennig A; Malissen B; Stoitzner P; Idoyaga J; Romani N
    J Immunol; 2012 Mar; 188(5):2146-55. PubMed ID: 22291181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression of co-signal molecules and migratory properties in four distinct subsets of migratory dendritic cells from the oral mucosa.
    Aramaki O; Chalermsarp N; Otsuki M; Tagami J; Azuma M
    Biochem Biophys Res Commun; 2011 Sep; 413(3):407-13. PubMed ID: 21893045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity.
    Kim WS; Kim H; Kwon KW; Im SH; Lee BR; Ha SJ; Shin SJ
    Oncotarget; 2016 Jun; 7(23):33765-82. PubMed ID: 27172902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD70-CD27 interaction augments CD8+ T-cell activation by human epidermal Langerhans cells.
    Polak ME; Newell L; Taraban VY; Pickard C; Healy E; Friedmann PS; Al-Shamkhani A; Ardern-Jones MR
    J Invest Dermatol; 2012 Jun; 132(6):1636-44. PubMed ID: 22377764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct Murine Mucosal Langerhans Cell Subsets Develop from Pre-dendritic Cells and Monocytes.
    Capucha T; Mizraji G; Segev H; Blecher-Gonen R; Winter D; Khalaileh A; Tabib Y; Attal T; Nassar M; Zelentsova K; Kisos H; Zenke M; Seré K; Hieronymus T; Burstyn-Cohen T; Amit I; Wilensky A; Hovav AH
    Immunity; 2015 Aug; 43(2):369-81. PubMed ID: 26231115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical steroid therapy induces pro-tolerogenic changes in Langerhans cells in human skin.
    Ali MA; Thrower SL; Hanna SJ; Coulman SA; Birchall JC; Wong FS; Dayan CM; Tatovic D
    Immunology; 2015 Nov; 146(3):411-22. PubMed ID: 26293297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Langerhans cells from human cutaneous squamous cell carcinoma induce strong type 1 immunity.
    Fujita H; Suárez-Fariñas M; Mitsui H; Gonzalez J; Bluth MJ; Zhang S; Felsen D; Krueger JG; Carucci JA
    J Invest Dermatol; 2012 Jun; 132(6):1645-55. PubMed ID: 22402444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. UVB-irradiated dendritic cells are impaired in their APC function and tolerize primed Th1 cells but not naive CD4+ T cells.
    Denfeld RW; Hara H; Tesmann JP; Martin S; Simon JC
    J Leukoc Biol; 2001 Apr; 69(4):548-54. PubMed ID: 11310840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mature human Langerhans cells derived from CD34+ hematopoietic progenitors stimulate greater cytolytic T lymphocyte activity in the absence of bioactive IL-12p70, by either single peptide presentation or cross-priming, than do dermal-interstitial or monocyte-derived dendritic cells.
    Ratzinger G; Baggers J; de Cos MA; Yuan J; Dao T; Reagan JL; Münz C; Heller G; Young JW
    J Immunol; 2004 Aug; 173(4):2780-91. PubMed ID: 15294997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of dendritic cell subsets in selection between tolerance and immunity.
    Belz GT; Heath WR; Carbone FR
    Immunol Cell Biol; 2002 Oct; 80(5):463-8. PubMed ID: 12225382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin.
    Geissmann F; Dieu-Nosjean MC; Dezutter C; Valladeau J; Kayal S; Leborgne M; Brousse N; Saeland S; Davoust J
    J Exp Med; 2002 Aug; 196(4):417-30. PubMed ID: 12186835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Revisiting the tolerogenicity of epidermal Langerhans cells.
    Lutz MB; Döhler A; Azukizawa H
    Immunol Cell Biol; 2010; 88(4):381-6. PubMed ID: 20212507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiation of Langerhans Cells from Monocytes and Their Specific Function in Inducing IL-22-Specific Th Cells.
    Otsuka Y; Watanabe E; Shinya E; Okura S; Saeki H; Geijtenbeek TBH; Takahashi H
    J Immunol; 2018 Nov; 201(10):3006-3016. PubMed ID: 30322965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.